61 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34994998 | Curcumin suppresses cell proliferation and triggers apoptosis in vemurafenib-resistant melanoma cells by downregulating the EGFR signaling pathway. | 2022 Apr | 3 |
2 | 33003239 | Curcumin Promotes Collagen Type I, Keratinocyte Growth Factor-1, and Epidermal Growth Factor Receptor Expressions in the In Vitro Wound Healing Model of Human Gingival Fibroblasts. | 2021 Feb | 6 |
3 | 34804186 | Bioinformatics Analysis to Screen Key Targets of Curcumin against Colorectal Cancer and the Correlation with Tumor-Infiltrating Immune Cells. | 2021 | 2 |
4 | 31545905 | Effects of somatostatin, curcumin, and quercetin on the fatty acid profile of breast cancer cell membranes. | 2020 Mar | 1 |
5 | 31793078 | Curcumin enhances radiosensitization of nasopharyngeal carcinoma by regulating circRNA network. | 2020 Feb | 2 |
6 | 32691972 | The in vivo preventive and therapeutic properties of curcumin in bile reflux-related oncogenesis of the hypopharynx. | 2020 Sep | 1 |
7 | 33178666 | Enhancing Bioavailability and Stability of Curcumin Using Solid Lipid Nanoparticles (CLEN): A Covenant for Its Effectiveness. | 2020 | 1 |
8 | 33246423 | A novel TGF-β receptor II mutation (I227T/N236D) promotes aggressive phenotype of oral squamous cell carcinoma via enhanced EGFR signaling. | 2020 Nov 27 | 2 |
9 | 30542713 | Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways. | 2019 Jan | 3 |
10 | 30899155 | Molecular designing, virtual screening and docking study of novel curcumin analogue as mutation (S769L and K846R) selective inhibitor for EGFR. | 2019 Mar | 1 |
11 | 31196210 | Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death. | 2019 Jun 13 | 4 |
12 | 31289524 | Radiosensitization effects of curcumin plus cisplatin on non-small cell lung cancer A549 cells. | 2019 Jul | 1 |
13 | 31432177 | Curcumin inhibits cell proliferation and migration in NSCLC through a synergistic effect on the TLR4/MyD88 and EGFR pathways. | 2019 Nov | 3 |
14 | 29157028 | Enhanced selective cellular uptake and cytotoxicity of epidermal growth factor-conjugated liposomes containing curcumin on EGFR-overexpressed pancreatic cancer cells. | 2018 Sep | 4 |
15 | 29445279 | EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles. | 2018 | 2 |
16 | 29620257 | Curcumin suppresses MUC5AC production via interfering with the EGFR signaling pathway. | 2018 Jul | 7 |
17 | 29700289 | RCP induces FAK phosphorylation and ovarian cancer cell invasion with inhibition by curcumin. | 2018 Apr 27 | 2 |
18 | 29805641 | Targeted therapy of triple negative MDA-MB-468 breast cancer with curcumin delivered by epidermal growth factor-conjugated phospholipid nanoparticles. | 2018 Jun | 1 |
19 | 30214301 | A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction. | 2018 | 1 |
20 | 30333889 | Synergistic inhibitory effects of cetuximab and curcumin on human cisplatin-resistant oral cancer CAR cells through intrinsic apoptotic process. | 2018 Nov | 1 |
21 | 28117012 | Current Status and Perspectives Regarding the Therapeutic Potential of Targeting EGFR Pathway by Curcumin in Lung Cancer. | 2017 | 1 |
22 | 28122302 | Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer. | 2017 Apr | 1 |
23 | 28286519 | ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases. | 2017 | 1 |
24 | 29052674 | EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy. | 2017 Nov 2 | 2 |
25 | 26505786 | Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways. | 2016 Jan 11 | 2 |
26 | 25753330 | Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects. | 2015 Apr 1 | 6 |
27 | 26468449 | Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention. | 2015 Oct 10 | 1 |
28 | 24318305 | Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling. | 2014 Aug | 2 |
29 | 24445050 | Down-regulation of epidermal growth factor receptor by curcumin-induced UBE1L in human bronchial epithelial cells. | 2014 Feb | 5 |
30 | 24491504 | Ensemble docking and molecular dynamics identify knoevenagel curcumin derivatives with potent anti-EGFR activity. | 2014 Apr 10 | 3 |
31 | 24508477 | Curcumin and (-)-epigallocatechin-3-gallate attenuate acrylamide-induced proliferation in HepG2 cells. | 2014 Apr | 1 |
32 | 25400722 | Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways. | 2014 | 8 |
33 | 23234806 | A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells. | 2013 Apr | 1 |
34 | 23245570 | Design, synthesis and molecular docking of α,β-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferative activity. | 2013 Jan 15 | 2 |
35 | 23880083 | Exploring pyrimidine-substituted curcumin analogues: design, synthesis and effects on EGFR signaling. | 2013 Sep 1 | 2 |
36 | 24512728 | Curcumin lowers erlotinib resistance in non-small cell lung carcinoma cells with mutated EGF receptor. | 2013 | 3 |
37 | 21567511 | Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells. | 2012 Jan | 2 |
38 | 22489192 | Curcumin: updated molecular mechanisms and intervention targets in human lung cancer. | 2012 | 3 |
39 | 23023821 | Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression. | 2012 Dec | 1 |
40 | 23194063 | Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. | 2012 Nov 30 | 2 |
41 | 21858220 | Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy. | 2011 | 5 |
42 | 21859497 | Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. | 2011 Aug 23 | 1 |
43 | 20332435 | Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. | 2010 Feb | 1 |
44 | 20407012 | Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells. | 2010 May | 6 |
45 | 19448398 | Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. | 2009 Jul | 3 |
46 | 19956394 | Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. | 2009 Dec | 2 |
47 | 17918158 | Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. | 2008 Jan 15 | 1 |
48 | 18214481 | Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells. | 2008 Oct | 2 |
49 | 18332871 | Activation of peroxisome proliferator-activated receptor-gamma by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells. | 2008 May | 4 |
50 | 18719366 | Androgen responsive and refractory prostate cancer cells exhibit distinct curcumin regulated transcriptome. | 2008 Sep | 1 |